The obesogen hypothesis states that together with an energy imbalance between calories consumed and calories expended, exposure to environmental compounds early in life or throughout lifetime might have an influence on obesity development. In this work, we propose a new approach for obesogen screening, i.e., the use of transcriptomics in the 3T3-L1 pre-adipocyte cell line. Based on the data from a previous study of our group using a lipid accumulation based adipocyte differentiation assay, several humanrelevant obesogenic compounds were selected: reference obesogens (Rosiglitazone, Tributyltin), test obesogens (Butylbenzyl phthalate, butylparaben, propylparaben, Bisphenol A), and non-obesogens (Ethylene Brassylate, Bis (2-ethylhexyl)phthalate). The high stability and reproducibility of the 3T3-L1 gene transcription patterns over different experiments and cell batches is demonstrated by this study. Obesogens and non-obesogen gene transcription profiles were clearly distinguished using hierarchical clustering. Furthermore, a gradual distinction corresponding to differences in induction of lipid accumulation could be made between test and reference obesogens based on transcription patterns, indicating the potential use of this strategy for classification of obesogens. Marker genes that are able to distinguish between non, test, and reference obesogens were identified. Well-known genes involved in adipocyte differentiation as well as genes with unknown functions were selected, implying a potential adipocyte-related function of the latter. Cell-physiological lipid accumulation was well estimated based on transcription levels of the marker genes, indicating the biological relevance of omics data. In conclusion, this study shows the high relevance and reproducibility of this 3T3-L1 based in vitro toxicogenomics tool for classification of obesogens and biomarker discovery. Although the results presented here are promising, further confirmation of the predictive value of the set of candidate biomarkers identified as well as the validation of their clinical role will be needed.
Health risk assessment of chemicals is still largely based on high dose exposure scenarios and evaluation of the adverse outcome in lab animals over short-to-long term periods. An alternative strategy for this low-throughput, time and cost intensive approach has been proposed by the U.S. National Research Council (NRC) report Toxicity testing in the 21st century: a vision and a strategy (NRC, 2007b) , encouraging the use of welldesigned in vitro assays. This might allow identifying effects of compounds on a cellular and molecular level for elucidation of so-called "toxicity pathways," a strategy that fits well in the 3R approach stimulated by the REACH legislation about reducing, replacing, and refining animal testing (ECHA, 2011) . Moreover, the increasing awareness of the importance and relevance of identifying these "toxicity pathways" reveals the potential of -omics techniques. By integrating -omics techniques with conventional toxicology, toxicogenomics studies the relation between the transcriptome and adverse biological effects caused by exposure to exogenous substances (Afshari et al., 2011) . Integration of transcriptomics with toxicology results in information on molecular mechanisms of action (MOA) and pathways involved in, or related to, a toxic effect. Next to the valuable mechanistic insights into toxicants obtained from such analysis, classification of compounds based on their transcription pattern may be possible. This approach fits well in the actual risk assessment strategy, by being valuable in predictive toxicology for prioritization of chemicals, in read across approaches for reducing the testing of closely related chemicals and in biomarker selection (NRC, 2007a) . McBurney et al. (2012) for instance showed that the use of biomarkers selected by toxicogenomics can result in a detection of drug candidates that have a greater toxicity potential in susceptible patients despite any indication for toxicity based on conventional toxicity studies.
This toxicogenomics approach, combining well-designed in vitro assays and transcriptomics, may also be valuable in the context of the recent environmental obesogen hypothesis. This hypothesis states that exposure to environmental compounds early in life or throughout lifetime might have an influence on obesity development . It is clear TOXICOGENOMICS BASED OBESOGEN SCREENING 353 from a recent report of the OECD concerning new testing strategies for endocrine disrupting compounds (EDCs) , that screening systems for metabolic disruptors, such as obesogens, are needed and that the 3T3-L1 cell line can be useful in a tiered approach for a first line selection of obesogens (OECD, 2012) . However, screening methods for obesogens used at the moment and proposed in the OECD report are mainly based on single endpoint testing such as the measurement of lipid accumulation or on activation/binding assays of the nuclear receptor PPAR␥ , a well-described target of many obesogens. Although this testing strategy is useful for a quick and relevant selection of compounds, a toxicogenomic approach might offer additional information for detecting mechanisms of obesogenic action. Furthermore, the 3T3-L1 cells are characterized as a stable, complete, and reproducible cell system for its use in toxicogenomics (Pereira-Fernandes et al., 2013b) . Therefore, the aims of this study are (1) to evaluate the stability of the 3T3-L1 cell line in toxicogenomics for its use in obesogen screening; (2) to evaluate the use of toxicogenomics for classification of obesogenic compounds; and (3) to select marker genes that discriminate obesogens from nonobesogens. For that reason, a broad range of human-relevant obesogenic compounds were selected based on a previous study where EDCs were screened in 3T3-L1 cells with a standardized adipocyte differentiation assay based on lipid accumulation (Pereira-Fernandes et al., 2013a) . Based on these results, the positive control (MDI), two reference obesogens [Rosiglitazone (ROSI), Tributyltin (TBT)], four test obesogens [Butylbenzyl phthalate (BBP), butylparaben (BP), propylparaben (PP), Bisphenol A (BPA)], and two non-obesogens [Ethylene Brassylate (EB), Bis (2-ethylhexyl)phthalate (DEHP)] were selected for this study as test compounds for the exploration of toxicogenomics in obesogen screening (Table 1) .
MATERIALS AND METHODS
3T3-L1 routine culture. 3T3-L1 mouse pre-adipocyte cells (American Type Culture Collection CRL-173, LGC Promochem GmbH, Wesel, Germany) were maintained in T75 Nunc culture flasks in standard medium composed of high glucose (4.5 g/l) Dulbecco's modified Eagle's medium (Life Technologies, Merelbeke Belgium) supplemented with 10% Heat Inactivated Newborn Calf serum (Life Technologies), 100 U/ml Penicillin, 100 g/ml Streptomycin (Life Technologies), and 1mM sodium pyruvate (Sigma-Aldrich). All cell culture experiments were performed in a 5% CO 2 atmosphere at 37
• C. Before they reach confluence, cells were detached using 0.25% Trypsin/EDTA (Life Technologies).
3T3-L1 exposure. Cells were seeded in 6-well plates at a density of 200,000 cells/well and grown until confluence. At the second day post confluence, denoted as day 0, growth medium was replaced by exposure medium containing 10% Heat Inactivated Foetal Bovine Serum instead of Newborn Calf Serum and supplemented with test compounds. Cells were exposed from day 0 until day 10, refreshing the medium with compound every 2-3 days. A solvent control (0.1% DMSO) was included. As a positive control, cells were stimulated with MDI hormonal cocktail (0.5mM isobutylmethylxanthine, 0.25M dexamethasone, and 10 g/ml insulin) from day 0 to 2 and thereafter with only insulin (10 g/ml) for another 8 days. As for the test compounds, the medium of the positive control was changed every 2-3 days.
Our previous microarray study with the reference obesogen TBT revealed a more complete gene transcription pattern when cells were exposed during 10 days (compared with 1 day) and to the highest effect concentration namely 50nM (PereiraFernandes et al., 2013b) . Consequently, the conditions selected for this study were non-cytotoxic concentrations (based on the Alamar Blue viability Assay) inducing a maximal degree of lipid accumulation (DLA) after 10 days of exposure (PereiraFernandes et al., 2013a) . Details about the selected compounds such as the suppliers and the concentrations tested are listed in Table 1 .
Microarray experiment. RNA extraction was performed using an RNeasy kit from Qiagen (Antwerp, Belgium), according to manufacturer's instructions. RNA purity and quality were evaluated using the NanoDrop spectrophotometer (NanoDrop Technologies, Montchanin, DE), integrity was checked using agarose gel electrophoresis. RNA was amplified and labeled using the Low Input Quick Amplification Labeling Kit (LIQA, Agilent, Diegem, Belgium), according to the protocol of the manufacturers and as described previously in Pereira-Fernandes et al. (2013b) . Thereafter, 825 ng of Cy3-and Cy5-labeled RNA samples was co-hybridized on a 4×44K whole mouse genome microarray (G4846A; Agilent) for 17 h at 65
• C in a continuously rotating hybridization oven. The hybridization design was a reference design (reference sample was a mixture of equal aliquots from control and exposed samples), recommended for class discovery purposes (Knapen et al., 2009 ). The reference sample was labeled with Cy5, and the exposed samples with Cy3. Three biological replicates were measured for every condition, and samples from different conditions were analyzed in a randomized manner. Arrays were washed with Agilent wash buffers and acetonitrile and finally submersed in stabilization and drying solution (Agilent Technologies) to prevent ozoneinduced Cy5-degradation. Slides were subsequently scanned using a Genetix Personal 4100A scanner (Axon Instruments, Union City, CA). The images were analyzed using the Genepix Pro software 6.1 (Axon Instruments) for spot identification and for quantification of the fluorescent signal intensities. Statistical analysis of microarray data was performed with the R package Limma (Smyth, 2004) as described in Vergauwen et al. (2010) . Briefly, spots for which red or green FG < BG + 2SD on all arrays were deleted before analysis (FG: medium foreground intensity; BG: average local background intensity calculated over Obesogenicity is based on the lipid accumulation based adipocyte differentiation assay from a previuos study and from the hierarchical clustering of the present study. In the previous paper, two selection criteria were developed for screening of obesogens (1) induction of a DLA higher than the lipid accumulation threshold (LAT) value or (2) based on the strictly standardized mean difference.
a According to the lipid accumulation based adipocyte differentiation assay published in Pereira-Fernandes et al. (2013a the full microarray; SD: standard deviation of local background intensities). After background correction (backgroundCorrect, method "normexp," offset = 50) of the median intensity data, loess normalization (normalizeWithinArrays) was applied. Linear models were fitted to intensity ratios, after which probes were ranked in order of evidence of differential transcription using an empirical Bayes method (Smyth, 2004) . Genes were regarded as significantly differentially transcribed versus solvent control considering a False discovery rate (FDR) ≤ 0.05 and |log 2 FC| ≥ 0.75 (log 2 fold change, corresponding to a 1.7-fold change). Microarray design details, raw data files, and normalized data are submitted to the NCBI GEO database (Reviewer only link: http://www.ncbi.nlm.nih.gov/geo/query/acc. cgi?token=qzaxycmuxzkxrof&acc=GSE53004 will be replaced by definite link after acceptance of the paper).
Pathway/GO analysis. The functional annotation tool of the DAVID bioinformatics resource (Huang et al., 2009 ) was used to identify common biological processes and pathways as defined by Gene Ontology (GO) criteria. For this analysis, the enrichment of GO terms in the target gene list (i.e., differentially transcribed genes) was compared, using Fisher's exact test, with a background list ("Agilent Mouse V2" as provided by DAVID) containing all genes analyzed. GO enrichment analysis of Biological Processes was performed by considering "GOTERM BP FAT," which is a selection of GO terms provided by DAVID, filtering the broadest terms to prevent overshadowing of the more specific terms. In this case, the specificity of a term is based on the number of child terms to eliminate the broadest term in the hierarchy. Pathway enrichment was carried out by selecting "KEGG pathways."
Hierarchical clustering and gene selection. Support Trees
Hierarchical clustering (HCL) with a Pearson distance metric and a complete linkage (with bootstrapping, n = 1000) was performed using the MultiExperiment Viewer (MeV, TIGR) (Saeed et al., 2003) . Log 2 FC of genes that were differentially transcribed in at least one of the nine test conditions (n = 1441) (and corresponding log 2 FC values of other conditions) were included in the analysis. This unsupervised clustering technique was used to form groups of compounds inducing a similar gene transcription profile. Subsequently, these groups were used for selection of marker genes able to discriminate between these groups using supervised Significance Analysis of Microarray (SAM).
PLS analysis.
A multivariate analysis, partial least squares (PLS; nonlinear iterative partial least squares (NIPALS)) was performed using JMP10.0, to evaluate the correspondence between microarray data (X) and a cell-physiological endpoint (Y) namely the DLA. DLA values were obtained from a previous study (Pereira-Fernandes et al., 2013a) . Here, log 2 FC of the top 50 marker genes selected with SAM analysis (X) were mapped to the DLA values (Y) induced by each compound. The DLA value (Y) is then estimated in terms of its reduced number of latent variables represented by a linear combination of log 2 FC values. KFold Cross validation technique was performed to evaluate the number of factors needed to adequately represent Y (with the lowest predicted residual sum of squares (PRESS)). Additionally, a van der Voet's test was applied to select the fewest number of factors with residuals that are insignificantly larger than the residuals of the model with minimum PRESS (van der Voet, 1994) . Two factors were enough to represent a significant model (van der Voet T 2 <0.000000). The genes that are good estimators of the Y response are identified by a measure called variable importance in the projection (VIP).
When genes have a VIP value >0.8 they are generally considered to be good estimators of the lipid accumulation outcome.
RESULTS

Reproducibility and Stability of Transcription Profiles
Comparison of the number of differentially transcribed genes observed in all treatments reveals that the positive control MDI caused the highest number of affected genes (1374), followed by the reference obesogens ROSI (861) and TBT (561) (Figs. 1A,  B) . The other positive obesogens, based on the lipid accumulation assay, caused substantially less differential transcription [PP (425), BP (379), BBP (147), BPA (230)], whereas the nonobesogens DEHP and EB only changed the transcription of none and one gene respectively and were therefore not shown in Figures 1A and 1B. The majority of differentially transcribed genes was transcribed with high significance (FDR≤0.0005) and was upregulated (Figs. 1A, B) .
To evaluate the stability of the cell system over different experiments and cell batches, the differential transcription values of corresponding conditions (TBT 50nM and MDI) of previously published microarray analysis were compared with those of the present experiment. Linear regression analysis was performed with all genes that were differentially transcribed in at least one of the nine test conditions (n = 1441) of the experiment (Figs. 1C, D) . Both regressions were highly significant (p<0.0001) and a strong R 2 was obtained for both treatments (TBT: R 2 = 0.79; MDI: R 2 = 0.83), indicating that very reproducible transcription profiles could be generated with the 3T3-L1 cell line.
Functional Annotation of the Transcriptomics Data
GO (Biological Processes) and KEGG pathway enrichment were performed, using DAVID software, to have an overview of the biological information in the gene transcription data. For each compound, top 10 of significantly enriched KEGG pathways and GO ontology terms were selected and a value of 10 was given to the most significantly enriched term/pathway whereas 1 was given to the least significant term/pathway. These scores of GO terms and pathways were then further summed and ranked to give an overview of the overall most important affected terms/pathways in the dataset (Fig. 2) . In this way, compounds can be compared per GO term/pathway, as can be seen in Figure 2 . All compounds caused a significant enrichment of the citric acid cycle and peroxisome proliferatoractivated receptor (PPAR) signaling pathway. Pathways involved in oxidative phosphorylation (Huntington, Alzheimer, Parkinson) were enriched by all compounds except for BBP and BPA. Nevertheless, glycerophospholipid metabolism, insulin signaling, and adipocytokine signaling were pathways only present in the top 10 of KEGG pathways enriched by BBP and BPA treatment.
The GO terms enriched after treatment with all of the compounds were involved in adipocyte differentiation (fat cell differentiation and brown fat cell differentiation). Oxidationreduction and generation of precursor metabolites and energy were enriched in all conditions except for BBP and BPA. Glycerol ether-, organic ether-, neutral lipid-, glycerolipid-, and triglyceride metabolic process were solely present in the top 10 GO terms enriched by BBP and BPA.
HCL and Marker Gene Selection
A total of 1441 genes were differentially transcribed in at least one of the nine conditions tested. On this gene set, HCL was applied to evaluate whether discrimination between obesogens and non-obesogens is feasible based on transcription data, and whether the grouping gave similar results compared with the one obtained in our previous study where two selection methods were used to evaluate the obesogenicity of the screened compounds based on the lipid accumulation (Table 1 , Fig. 3A ). HCL analysis using complete linkage and Pearson correlation metric revealed a clear discrimination (bootstrap values of 100%) of obesogenic and non-obesogenic compounds and furthermore, two distinctive groups of obesogenic compounds were clustered (corresponding to test and reference groups in Fig. 3A) . Additionally, HCL analysis performed with average linkage or using the often used Euclidian distance gave similar results (data not shown). Within the cluster of the test compounds, the two structure analogues PP and BP induced highly similar transcription profiles as shown by the high Pearson correlation coefficient and bootstrap value of the cluster. Interestingly, when these results were compared with the grouping of the previous study (Pereira-Fernandes et al., 2013a) both SSDM and the HCL revealed the grouping of similar compounds. Except for BBP that was selected as a strong compound based on the SSDM method.
Selection of Marker Genes
Because both the SSDM-based grouping from previous study and the one of the HCL gave similar results, SAM was performed to select endocrine, obesogen-related marker genes, which are able to discriminate between the three different groups of the HCL cluster (non, test, and reference). The top 50 marker genes selected are indicated in Table 2 and classified based on the functional annotation of the genes. Several genes selected were involved in adipocyte differentiation-related pathways or GO terms (Adipocyte differentiation, PPAR signaling, Adipokine signaling, Lipid metabolism, and Oxidationreduction process) but others were involved in other pathways or GO terms involved in, e.g., apoptotic processes, TCA cycle, calcium transport, or pyruvate metabolism whereas a third group of genes have an unknown function. Additionally, an HCL analysis of the genes was performed, based on these 50 marker genes (Fig. 3B) to analyze the similarity of transcrip- Gene transcription values from the present study were compared with those of identical conditions (50nM TBT (C) and MDI (D)) from a previous experiment, and a linear regression analysis was performed. For each condition 3T3-L1 cells were exposed for 10 days.
FIG. 2.
KEGG pathway and GO (Biological Processes) enrichment of differentially transcribed genes after exposure to test compounds. For each compound, top 10 of significantly enriched KEGG pathways (A) and GO terms (B) were selected and ranked based on the significance level (Rank 10 = most significant; Rank 1 = least significant). These scores of GO terms and KEGG pathways were then further summed and ranked to give an overview of the overall most important affected terms/pathways in the dataset.
FIG. 3.
Dendrogram of HCL and heatmap of marker genes selected with SAM. HCL (complete linkage HCL, using Pearson's correlation coefficient as distance measure) based on log2 FC ratios of differentially transcribed genes after 10 days of exposure in the 3T3-L1 cells. When a gene was differentially transcribed in one of the nine conditions, the corresponding Log2 ratios of the other conditions were included in the analysis (n = 1441) Bootstrap values (expressed in percentages; 1000 iterations) are indicated below the nodes (A). Heatmap and HCL (complete linkage, Pearson's correlation coefficient as distance measure) of the log2 FC ratios of the 50 marker genes selected with SAM analysis (B). tion between the marker genes. Interestingly, CD36 and Fabp4 generally used marker genes for mature adipocytes clustered together with Reep 6, a gene with an unknown function indicating its possible involvement in adipocyte differentiation.
To further evaluate the stability of the gene expression profile of the cells, the transcription of this set of marker genes was compared with those of identical conditions from a previous study performed in Pereira-Fernandes et al. (2013b) . Linear regression analysis was performed with the 50 marker genes (Figs.  4A, B) . Both regressions were highly significant (p<0.0001) and a strong R 2 was obtained for both treatments (TBT: R 2 = 0.84; MDI: R 2 = 0.89), confirming the stability of the gene expression profiles generated in the 3T3-L1 cell line.
Comparison of Transcriptomics with the Adipocyte Differentiation Assay
To evaluate the relevance of the selected marker genes, the association between cell-physiological endpoints such as the DLA (Pereira-Fernandes et al., 2013a) and the transcription data was evaluated using a PLS analysis. The top 50 marker genes selected with SAM were used to represent the microarray data. A significant model was generated (van der Voet T 2 = 0.003) and two factors were sufficient to capture the relationship between the DLA and the transcription values. This model represents 93% of the variance in DLA, using 94% of the variance in microarray data. All 50 marker genes had a VIP value higher than 0.8, indicating high importance of all marker genes in estimation of lipid accumulation in the 3T3-L1 cells. Additionally, the estimated DLA values based on microarray data were plotted against the actual observed DLA (Fig. 4) . Linear regression analysis defined an R 2 of 0.92 and a slope of 1, indicating a very good estimation of the DLA values based on the transcription data.
DISCUSSION
Because the discovery of the obesogenic potential of TBT , one of the first and most studied obesogenic compounds, the evaluation of possible adipogenic potential of other environmental compounds has received increasing attention. Multiple human-relevant compounds were recently screened in vitro as adipogenic, including phthalates [e.g., BBP, DiBP (Pereira-Fernandes et al., 2013a) ], parabens [PP and BP (Hu et al., 2012) ], and BPA (Masuno et al., 2002) . All these obesogenic compounds have been detected using mainly a single endpoint approach, based on lipid accumulation, sometimes confirmed by gene expression levels of adipocyte-specific marker genes. However, in this study the aim was to evaluate whether an inherent multi-endpoint approach such as toxicogenomics could be useful for detection of obesogenic compounds and whether it could provide important additional mechanistic information.
Suitability of the 3T3-L1 Cells for Toxicogenomic Studies
A highly stable transcription profile was obtained for all treatments (FDR≤0.0005) as in our previous microarray study in the 3T3-L1 cell line (Pereira-Fernandes et al., 2013b) . However, Goetz et al. (2011) have indicated possible limitations for the use of transcriptomics due to the variability obtained from experiments performed in different laboratories, with different strains or different time points of exposure. Comparing the present transcription results with those of identical treatments of a previous study performed in the lab [TBT 50nM and MDI (Pereira-Fernandes et al., 2013b) ] revealed strongly reproducible transcription patterns. As such, variation between both studies such as different ATCC batches, different stocks of compounds, and experiments performed with a year of interval were included. This finding is of major importance for the future use of 3T3-L1 cells in toxicogenomics. This indicates that future evaluation of obesogenicity of new compounds will be possible by combination and comparison of future experiments with previously obtained transcription patterns. However, an evaluation of inter-laboratory differences is needed for further validation of the transcriptomic use of 3T3-L1 cells.
In the previous microarray study of ours, the effect of two different concentrations (low and high) of TBT was analyzed in detail and similar patterns in gene expression were obtained for both concentrations although clearer effects were observed after exposure to the high dose (Pereira-Fernandes et al., 2013b) . Therefore in this paper we have tested the compounds at concentrations inducing maximal DLA to be sure to have clear transcriptomics effects. However, it should be noted that these concentrations induce different DLA values in the 3T3-L1 cells and that these differences in potencies between the compounds could be a confounding factor for the mechanistic interpretation of our results. Therefore in future experiments it would be interesting to additionally compare the gene expression pattern induced by equipotent concentrations of compounds.
Transcriptomics and Grouping of Compounds
Transcription analysis indicated that compounds inducing the highest DLA (MDI, ROSI, TBT) induced the highest number of differentially transcribed genes. In addition, the absence of affected genes after DEHP and EB treatment confirmed the previously observed lack of obesogenicity (based on the DLA) of these compounds (Table 1) .
To evaluate the similarity in transcription between samples, HCL was used as unsupervised clustering strategy, as proposed by Eisen et al. (1998) for class discovery. Discrimination between non-obesogenic (EB and DEHP) and obesogenic compounds was possible. Furthermore, according to the high bootstrap values (≥90%) the obesogenic compounds could be subdivided into two classes defined here as test and reference obesogens and are in accordance with the differences in lipid accumulation induced by compounds of both groups (Table 1) . Concerning the reference group, TBT and ROSI induced a highly similar transcription profile (indicated by the high Pearson correlation value), probably due to the fact that they are both strong PPAR␥ agonists (Li et al., 2011) . The test group consisted of compounds that showed a weaker obesogenic response in the 3T3-L1 lipid accumulation assay, namely BPA, BBP, and the two parabens PP and BP (Table 1 ). The high similarity in transcription between the two structure analogues PP and BP is shown by the highly significant Pearson correlation coefficient, and suggests a structure-related mechanism of action. Interestingly, both parabens have been shown to activate the PPAR␥ and glucocorticoid receptor (GR) (Hu et al., 2012; PereiraFernandes et al., 2013a) . Based on the transcription data, BPA was the most distinct compound of this group, indicating that this compound might act through a different mechanism of action. Indeed BPA is the sole compound of this cluster that only weakly activated the PPAR␥ receptor in our previous study (Pereira-Fernandes et al., 2013a) . Moreover, Sargis et al. (2010) reported the GR binding capacity of BPA, whereas Masuno et al. (2005) indicated a phosphatidylinositol 3-kinase pathway dependent induction of differentiation. Together all these studies show that the obesogenic mechanism of action of BPA remains enigmatic, but seem to be different from the frequently observed PPAR␥ mediated obesogenicity. Including other obesogenic compounds with low PPAR␥ activation capacity in future microarray experiments could further confirm the distinction of the BPA gene expression profile compared with PPAR␥ agonists, and aid to unravel in more detail the mode of action of these compounds.
Functional annotation of the transcription results revealed a similar picture, where BBP and BPA induced the enrichment of different GO terms and KEGG pathways compared with those of other compounds. Overall, there was a significant enrichment of PPAR signaling and citric acid cycle KEGG pathways after treatment with each of the tested obesogens. Accordingly, both pathways were significantly enriched during adipocyte differentiation in our previous microarray study with TBT and the citric acid cycle was in the proteomic study of Newton et al. (2011) .
Selection of Marker Genes and Comparison with a Single Endpoint Test
Selection of marker genes from transcriptomics studies has shown to be valuable in many fields such as toxicology, personalized medicine, or drug development because in general, genomic biomarkers are frequently known to be more sensitive than functional or morphological markers (Searfoss et al., 2005; Smith et al., 2013) . Therefore, toxicity of a compound can be detected earlier, even before physiological effects, or additionally compounds inducing subtle effects or acting only in susceptible subjects can be detected (McBurney et al., 2012) . In this study, the top 50 genes were identified that were able to distinguish between the non, test, and reference obesogens. As expected, fatty acid binding protein 4 [Fabp4, also called adipocyte-specific protein 2 (aP2)] and the scavenger receptor Cd36, generally used as marker genes for adipocytes, were also identified as marker genes in this study. Interestingly, other genes that were to our knowledge never used as marker genes clustered together with Fabp4 and Cd36: adipocyte-related Xchromosome expressed sequence 2 (Arxes2) and receptor accessory protein 6 (Reep 6) where the latter has never been associated with adipocyte differentiation (Prokesch et al., 2011) . This indication of co-transcription implies that these genes could be interesting target genes for future obesity or adipocyte differentiation studies. Additionally, other genes previously associated with adipocyte differentiation such as perilipin 2 (Plin2) involved in lipid droplet storage and melanocortin 2 receptor accessory protein (Mrap) and phosphoenolpyruvate carboxykinase 1 (Pck1) were selected as potential marker genes (Xu et al., 2002) . The nuclear receptors LXR (Nr1h3) and retinoid X receptor ␥ (Rxrg) were additionally indicated as marker genes. RXR plays an important role in adipocyte differentiation, because it can form a permissive heterodimer with PPAR␥ , which, when activated, can induce the differentiation of adipocytes. On the other hand, LXR controls lipid and cholesterol homeostasis, and its expression, regulated by PPAR␥ , is high in adipose tissue (Seo et al., 2004) . However, the role of LXR during adipocyte differentiation is still controversial. Hummasti et al. (2004) showed that stimulation of 3T3-L1 cells with LXR agonists did not alter the lipid accumulation of 3T3-L1 cells, whereas Juvet et al. (2003) showed opposite results. Remarkably, next to these adipocyte-related marker genes, more general genes involved in the oxidation-reduction process or in lipid metabolism were selected as candidate marker genes. A possible explanation could be that these genes are general response genes induced after chemical exposure, but this is unlikely because we have included two non-obesogenic compounds in our study to be able to discriminate general from specific obesogenrelated effects. Interestingly, several genes with currently unknown function were also selected, indicating the potential role of some of them in adipocyte differentiation.
Interestingly, the heatmap constructed using the transcription levels of the top 50 marker genes selected from this study indicates that the transcription level of the marker genes was high after treatment with reference obesogenic compounds, moderate for test obesogens and not differentially regulated for nonobesogenic compounds (Fig. 3) . This demonstrates that toxicogenomic classification can group chemicals based on their effect and MOA but also to a certain extent based on the degree of differential gene transcription. Although these results are promising, they need to be confirmed using a broader set of compounds (both obesogenic and non-obesogenic) in the future.
In risk assessment, the more firmly a change in gene expression can be related to an adverse outcome (phenotypic anchoring) the more meaningful and useful the results are (Paules, 2003) . This fits into the recently formulated conceptual framework called the adverse outcome pathway (AOP). The AOP is a conceptual construct of existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment (Ankley et al., 2010) . Therefore, the association between the gene transcription level of the selected marker genes and the DLA induced by the tested compounds was evaluated to further support the AOP concept. Linear regression analysis indicated a very good estimation capacity of the transcription data of the marker genes for lipid accumulation results. Although these results are promising, further confirmation of the relevance value of this set of candidate biomarkers is needed using transcription profiles of other obesogens and non-obesogens.
Additionally, it should be stated that this toxicogenomics approach or the measurement of well-confirmed marker genes selected from such analysis is more labor and cost intensive compared with a single endpoint assay such as a lipid accumulation assay. Nevertheless, up to now there is no established standard method to evaluate the relevance of in vitro measured obesogenicity in particular in the context of in vivo predictivity. The extra mechanistic information obtained by measuring gene expression has proven its utility in the context of in vivo prediction and inter-species extrapolation, such as in the so-called parallelogram approach of Kienhuis et al. (2009) using rat-human in vitro and rat in vivo toxicogenomics to predict Acetaminopheninduced hepatotoxicity in humans. Moreover, gene expression analysis is valuable for the evaluation of the mode of action of compounds, and the grouping of compounds with similar modes of action, which is not feasible using for instance a lipid accumulation assay. Future experiments will have to be performed to evaluate the possibility for in vivo prediction based on in vitro data in the context of obesogenicity screening, but as it currently stands in our opinion a combination of lipid accumulation with gene expression of a set of well selected and validated marker genes is the way to go for first line screening of obesogenic compounds. Although further studies are needed for selection and validation of a set of marker genes.
CONCLUSION
As previously mentioned, the OECD has pointed out the need for new testing strategies for metabolic disruptors, such as obesogens (OECD, 2012) . Screening methods proposed in the OECD report are mainly based on single endpoint testing and the use of the 3T3-L1 cell line is recommended. In this study, we propose an alternative screening method based on the transcription of identified marker genes. Our microarray study demonstrates the potential of combining the 3T3-L1 in vitro assay with toxicogenomics for obesogen screening. A distinction between non, test, and reference obesogens was feasible based on the transcriptomics profiles, indicating the potential use of this strategy for classification of obesogens. The clear relationship between transcription levels of the marker genes and the cell-physiological results indicate the biological relevance of toxicogenomic data. Although this in vitro toxicogenomics tool is promising for future classification of, e.g., obesogens, experiments using a broader range of both obesogenic and nonobesogenic compounds will have to confirm the present findings and the in vivo predictability of these effects still needs to be tested.
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